Which stocks in any sector do Indian mutual fund managers prefer most? — October 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 478 funds | 2.50% | ₹59,605 Cr |
| 2 | Divi's Laboratories Limited | 391 funds | 2.76% | ₹36,319 Cr |
| 3 | Torrent Pharmaceuticals Limited | 351 funds | 2.03% | ₹14,040 Cr |
| 4 | Cipla Limited | 308 funds | 1.54% | ₹23,762 Cr |
| 5 | Dr. Reddy's Laboratories Limited | 296 funds | 1.64% | ₹20,946 Cr |
| 6 | Lupin Limited | 239 funds | 1.49% | ₹12,941 Cr |
| 7 | Aurobindo Pharma Limited | 234 funds | 1.69% | ₹9,857 Cr |
| 8 | Mankind Pharma Limited | 224 funds | 1.18% | ₹11,475 Cr |
| 9 | Laurus Labs Limited | 215 funds | 3.34% | ₹10,513 Cr |
| 10 | Glenmark Pharmaceuticals Limited | 205 funds | 1.31% | ₹7,719 Cr |
| 11 | Ajanta Pharma Limited | 204 funds | 1.00% | ₹8,005 Cr |
| 12 | Zydus Lifesciences Limited | 201 funds | 1.19% | ₹7,354 Cr |
| 13 | Biocon Limited | 197 funds | 0.97% | ₹13,220 Cr |
| 14 | Alkem Laboratories Limited | 184 funds | 1.25% | ₹12,244 Cr |
| 15 | Gland Pharma Limited | 184 funds | 1.39% | ₹15,681 Cr |
| 16 | Sai Life Sciences Limited | 183 funds | 1.44% | ₹10,070 Cr |
| 17 | IPCA Laboratories Limited | 171 funds | 1.22% | ₹15,646 Cr |
| 18 | Acutaas Chemicals Ltd | 170 funds | 1.55% | ₹4,700 Cr |
| 19 | Abbott India Limited | 169 funds | 0.91% | ₹4,349 Cr |
| 20 | Anthem Biosciences Limited | 162 funds | 0.67% | ₹4,577 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of October 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.